Orchestra BioMed Holdings OBIO
NASDAQ OBIO
$5.59 +0.12 (+2.19%)
At close: Oct 23, 2026 · 4:00 PM EDT

Orchestra BioMed Holdings (OBIO) Amortization of Deferred Charges (2022 - 2026)

Updated

Analysis

Orchestra BioMed Holdings (OBIO) Amortization of Deferred Charges (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.13 Bn 229.16 Bn 4.88 Bn
2 Abbott Laboratories 180.31 Bn 150.74 Bn 7.27 Bn
3 Danaher 162.34 Bn 146.15 Bn 3.61 Bn
4 Intuitive Surgical 158.13 Bn 138.42 Bn 2.08 Bn
5 Medtronic 122.37 Bn 87.63 Bn 6.34 Bn
6 Stryker 117.89 Bn 104.00 Bn 4.50 Bn
7 Boston Scientific 67.15 Bn 61.92 Bn 3.85 Bn
8 Becton Dickinson 54.68 Bn 51.83 Bn 2.32 Bn
9 Edwards Lifesciences 51.43 Bn 35.44 Bn 1.35 Bn
10 Orchestra BioMed Holdings 354.80 Mn -51.90 Mn 63,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 65,000.00
Mar 31, 2026 64,000.00
Dec 31, 2025 64,000.00
Sep 30, 2025 59,000.00
Jun 30, 2025 46,000.00
Mar 31, 2025 46,000.00
Dec 31, 2023 3,000.00
Sep 30, 2023 36,000.00
Jun 30, 2023 37,000.00
Mar 31, 2023 36,000.00
Dec 31, 2022 36,000.00
Sep 30, 2022 36,000.00
Jun 30, 2022 36,000.00
Mar 31, 2022 55,000.00
API Access

Orchestra BioMed Holdings Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=OBIO&period=max&api_key=YOUR_API_KEY